In conclusion, these findings indicate that the SRF/IGF2BP1-dependent control of gene expression in cancer is largely conserved, promotes the synthesis of factors enhancing tumor cell growth and is associated with unfavorable prognosis in three solid cancers. Here, IGF2BP1 is linked to cancer.